NEW — CDC/FDA Study Confirms Hundreds of Cases of Guillain-Barré Syndrome After COVID-19 Vaccination
“We identified 295 verified GBS cases among VAERS reports submitted from Dec 2020 through Jan 2022.
GBS was the documented cause of death after…review for 7 individuals.”
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800871
https://twitter.com/thechiefnerd/status/1622032982318977025
@ChiefNerd
THIS WILL NOT END WELL: NSA Courting THOUSANDS Of Fired Woke Big Tech Workers For Intelligence Activities
Thousands of terminated far-left Big Tech workers may soon have prominent positions in America’s most notorious spying agency. The Nation Security Agency (NSA) is embarking on one of their biggest hiring sprees in the last three decades. Big tech workers…
https://www.thegatewaypundit.com/2023/02/will-not-end-nsa-courting-thousands-fired-woke-big-tech-workers-intelligence-activities/
The Gateway Pundit
True…never let them out of your sight
https://twitter.com/paulsperry_/status/1621986431810813955?s=46&t=HxXrkfNoTcONMRdGCz5Weg
https://twitter.com/paulsperry_/status/1621967806735548425?s=20&t=W_asohRLoznBL3JHSJjQxg
https://twitter.com/paulsperry_/status/1621986431810813955?s=46&t=HxXrkfNoTcONMRdGCz5Weg
𝕀𝕟 𝕄𝕒𝕘𝕟𝕒 𝔼𝕩𝕔𝕚𝕥𝕒𝕥𝕚𝕠
Forwarded from Evans_Baked
In case you had any doubt on whether we are the majority, here’s a little sampling, by the numbers…
MTG’s post: 6.4 million views, 86.5k likes
Swalwell’s rebuttal: 154k views, 3,200 likes
No matter how hard the entire fake news media tries to convince you that America is split evenly, the truth is that the establishment & the shills who push their narrative are on the verge of extinction.
The Great Awakening.
The Purposely Sleeping Clown O'Biden Admin & their minions
Meanwhile in the Northern European country of Sweden, where Northern Europeans are supposed to be.
https://twitter.com/dvatw/status/1621415529113157632?s=46&t=C2txHUzm6KAeA0k-1am4aw
Get them out of your country, period! They are there to destroy it.
NOW
Los Angeles, Happening Now: Antifa militants held vigil for the Chinese Surveillance Balloon.
Mayo Clinic CEO is on the board of Merck…Merck’s Taxpayer-Subsidized COVID Pill Linked to New Virus Mutations, Study Finds
Merck’s oral antiviral pill for COVID-19, molnupiravir — marketed under the name Lagevrio — may be fueling the development of new and potentially deadly variants of COVID-19, according to the authors of a new preprint study.
Merck’s oral antiviral pill for COVID-19, molnupiravir — marketed under the name Lagevrio — may be fueling the development of new and potentially deadly variants of COVID-19, according to the authors of a new preprint study.
The study, released Jan. 27 by a team of U.S. and U.K researchers, found, “It is possible that some patients treated with molnupiravir might not fully clear SARS-CoV-2 infections, with the potential for onward transmission of molnupiravir-mutated viruses.”
Merck received significant taxpayer funding from the Biden administration to develop and distribute molnupiravir, and the U.S. government bought nearly 2 million courses of the drug on the taxpayer’s dime.
The study, which is pending peer review, followed the discovery by a middle school science and math teacher in Indiana who found numerous variants of COVID-19 emerged after molnupiravir began to be widely distributed.
Scientists had long warned that the development of such mutations from the use of molnupiravir was possible.
“It’s not a surprise that molnupiravir could cause [the] escape of mutant virus strains or substrains into the population,” said Dr. Harvey Risch. “Its main function is to get the virus to mutate faster.”
Risch, professor emeritus and senior research scientist in epidemiology (chronic diseases) at the Yale School of Public Health, told The Defender:
“The idea is that it will mutate itself to death. But some live mutants could get out, and this paper gives evidence that they have.”
Brian Hooker, Ph.D., P.E., chief scientific officer for Children’s Health Defense, said the study’s authors scanned global SARS-CoV-2 sequence databases looking for mutations characteristic of those by molnupiravir (G-to-A and C-to-U) and found an uptick of those mutants starting in 2022 — after molnupiravir was put on the market and specifically in countries where molnupiravir was distributed.
“Although this isn’t ‘direct proof’ that the mutations came directly from molnupiravir use,” Hooker told The Defender, “the evidence is very compelling, confirming the fears of many who warned of this prior to FDA [U.S. Food and Drug Administration] approval of the drug in late 2021.”
The FDA granted molnupiravir Emergency Use Authorization (EUA) on Dec. 23, 2021, for use in mild-to-moderate COVID-19 infections in patients 18 and over.
The EUA came just one day after the FDA authorized Pfizer’s COVID-19 antiviral treatment Paxlovid.
Merck this week announced massive revenues from sales of molnupiravir in 2022, but projected a significant decrease in those sales in 2023.
The FDA on Wednesday removed the requirement that a person has to test positive for COVID-19 in order to get a prescription for molnupiravir or Paxlovid.
‘I think we are courting disaster’
Molnupiravir “works by creating mutations in the COVID-19 genome that prevent the virus from replicating in the body, reducing the chances it will cause severe illness,” according to Bloomberg.
However, according to Science, the findings of the preprint study suggest “some people treated with the drug generate novel viruses that not only remain viable, but spread.”
This finding “underscores the risk of trying to intentionally alter the pathogen’s genetic code,” leading some researchers to “worry the drug may create more contagious or health-threatening variations of COVID,” Bloomberg reported.
Virologist William Haseltine, Ph.D., chair and president of ACCESS Health International, has repeatedly raised such concerns about molnupiravir.
“It’s very clear that viable mutant viruses can survive [molnupiravir treatment] and compete [with existing variants],” Haseltine told Science. “I think we are courting disaster.”
https://childrenshealthdefense.org/defender/merck-covid-pill-virus-mutations/